Home · Guides · Two medications
Two medicationsAlready on metformin? What changes if you add a GLP-1 for PMOS
Metformin is often the first medication women with PMOS are given. If a GLP-1 is next, here is how the two fit together.
If you have PCOS (PMOS), there is a good chance metformin was the first prescription you were offered. It targets insulin resistance, which sits at the centre of the condition for most women, and it has been used in PMOS care for a long time. So when a GLP-1 comes up, one of the first questions is practical: do I stop the metformin, keep it, or does it not matter?
That decision belongs to your clinician. What follows is what to understand going in, so the conversation is a good one.
Why they are often discussed together
Both medications work on the metabolic side of PMOS, in different ways. Metformin mainly reduces how much glucose the liver releases and improves how the body responds to insulin. GLP-1 medications such as tirzepatide act on hormone pathways that affect appetite, digestion and insulin release, and in trials they produce much larger weight loss than metformin.
They are not strangers. In diabetes trials, tirzepatide was routinely studied in people already taking metformin. In PMOS specifically, a number of small trials have combined metformin with an earlier GLP-1 medication and generally reported more weight loss than metformin alone. Those PMOS trials were small and short, so they are a reason to take the combination seriously, not proof of what it will do for you.
The side-effect overlap
This is the part to plan for. Metformin’s most common side effects are gastrointestinal: nausea, diarrhea, stomach upset. So are a GLP-1’s. If you start a GLP-1 while taking metformin, those effects can stack, especially in the first weeks and after each dose increase. A provider who knows you are on metformin may start lower, step up more slowly, or review your metformin dose or formulation with you. A provider who never asks cannot do any of that.
Labs worth keeping on the calendar
- A1c and fasting insulin, to see how the metabolic picture changes over time. We explain both in the five labs to ask for.
- Vitamin B12, which long-term metformin use can lower. It is a routine check worth asking about if it has not been done recently.
- Blood sugar awareness. Metformin and a GLP-1 together carry a low risk of low blood sugar on their own. That risk rises if you also take insulin or a sulfonylurea, which your provider needs to know about.
Two medications aimed at the same root need one plan, not two prescribers guessing.
Questions for your provider
Before your first GLP-1 dose
- “I take metformin, at this dose. Do you want me to continue it, and will you adjust anything while we titrate?”
- “How will you tell which medication is causing a side effect?”
- “Which labs will you track, and how often?”
- “Who should I contact if GI side effects get hard to manage?”
Those questions map onto Lantana’s Root Eight: root-cause metabolic care, labs that look deeper, a dose made for your body, and a person you can reach. You can see how the thirteen providers score on each in the full comparison.
Do not stop or change metformin on your own because you are starting something new. GLP-1 medications are not FDA-approved to treat PCOS (PMOS); where symptoms improve, that follows from weight loss and better insulin sensitivity. Compounded tirzepatide is not FDA-approved or reviewed by the FDA for safety or efficacy. Nothing here is medical advice.